Nasdaq-listed Sonnet BioTherapeutics agrees to $888 million merger to become Hyperliquid Strategies, launch HYPE treasury

theblock.co/post/362417/hyperliquid-strategies-hype-treasury

This story appeared on theblock.co, 2025-07-14 14:58:05.649000.
The Entire Business World on a Single Page. Free to Use →